Xtacy Therapeutics Corp.
Xtacy Therapeutics Corp.
Indice CSE:
Devise:
Xtacy Therapeutics Corp is a prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for wellness consumer products. The present focus of the company is in hemp and CBD-related, psilocybin and functional mushrooms, and health-care related industries.
Xtacy Therapeutics Corp. (XTCY)
SEDAR Information
Information d'entreprise
Addresse
702-595 Howe Street
Vancouver, BC V6C 2T5
CanadaTéléphone
604-484-8989Courriel
[email protected]URL
https://www.redfundcapital.comDate d’inscription à la cote
Jeudi, juillet 16, 2009
Agent de transfert
Computershare Investor Services Inc.Relations avec les investisseurs
604-245-5974Courriel
[email protected]Vérificateur
Dale Matheson Carr-Hilton Labonte LLPCapitalisation
Capitalisation:
49,214,971Réservé à l'émission:
3,919,446Company Officers
Meris Kott, Director, CEO
Mark Ireton, Director
Lindsey Perry Jr., Director and CFO
Ashleigh Vogstad, Director
Communiqués de presse
Bulletins
25/09/2023
2023-0929 - Changement de Nom et de Symbole - Global Wellness Strategies Inc. (GWS)
le 25 septembre/September 2023
Global Wellness Strategies Inc. (GWS) has announced a name and symbol change to Xtacy Therapeutics Corp. (XTCY)
Shares will begin trading under the new name and symbol and with a new CUSIP number on September 26, 2023.
Disclosure documents are available at www.thecse.com.
Advertisement
Publicité
Évènements à venir
90th Annual Market Structure Conference
Mercredi, octobre 11, 2023 (Jour entier) - Vendredi, octobre 13, 2023 (Jour entier)
